Company intelligence / Profile preview

Serendex Pharmaceuticals

Hørsholm/Copenhagen area, Capital Region of Denmark/Hovedstaden, Denmarkserendex.com ↗

Ownership: Private
Development stage: Phase 3

Overview

Serendex developed a pipeline of inhaled therapies for rare and severe respiratory diseases. Its most advanced asset was Molgradex®—inhaled molgramostim—for autoimmune pulmonary alveolar proteinosis, which reached Phase II/III clinical trials. The company pursued drug repositioning strategies with orphan drug designations to accelerate development timelines. In July 2016, it was acquired by Savara Pharmaceuticals.

Therapeutic areas: PulmonologyInfectious Diseases
Modalities: Inhaled biologics (notably GM-CSF/molgramostim and Factor VIIa)Repositioned small molecules (e.g., fosfomycin)
Industry: Biotech

Drug pipeline

2 assets

inhaled gm-csf

Phase 3

Indications: Pulmonary alveolar proteinosis, Acute respiratory distress syndrome

1 more asset in the full pipeline.

Partnerships

CMC Biologics for manufacturing support of Factor VIIa programVarious pharma/drug development collaborations globally

Beyond the preview

Go deeper on Serendex Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Serendex Pharmaceuticals.